David van de Vijver
- Infectious Diseases top 0.5%
- Virology top 0.2%
- Epidemiology top 1%
- Molecular Biology
- Immunology top 10%
- Co-authors
- Charles A. BoucherAnne–Mieke VandammeAlbert D. M. E. OsterhausRicardo CamachoMarc J. M. BontenMarion KoopmansGuus F. RimmelzwaanBrooke E Nichols
- Topics
- HIV/AIDS Research and Interventions (54 papers)HIV Research and Treatment (49 papers)HIV/AIDS drug development and treatment (37 papers)
- Journals
- ScienceNucleic Acids ResearchSHILAP Revista de lepidopterología
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
David van de Vijver
116 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Infectious Diseases 2.8k
- Virology 1.8k
- Epidemiology 1.6k
- Molecular Biology 401
- Immunology 245
Countries citing papers authored by David van de Vijver
This map shows the geographic impact of David van de Vijver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David van de Vijver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David van de Vijver more than expected).
Fields of papers citing papers by David van de Vijver
This network shows the impact of papers produced by David van de Vijver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David van de Vijver. The network helps show where David van de Vijver may publish in the future.
Co-authorship network of co-authors of David van de Vijver
This figure shows the co-authorship network connecting the top 25 collaborators of David van de Vijver. A scholar is included among the top collaborators of David van de Vijver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David van de Vijver. David van de Vijver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 7 | |
| 4 | 9 | |
| 5 | 8 | |
| 6 | From more testing to smart testing:data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020 | 7 |
| 7 | 3 | |
| 8 | 10 | |
| 9 | 4 | |
| 10 | 29 | |
| 11 | 17 | |
| 12 | 40 | |
| 13 | 18 | |
| 14 | [Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine]. | 1 |
| 15 | Pre-exposure prophylaxis (PrEP) will have a limited impact on the prevalence of HIV-1 drug resistance in sub-Saharan Africa: comparison of mathematical models | 1 |
| 16 | 1 | |
| 17 | Test and treat for prevention of new HIV infections | 1 |
| 18 | 75 | |
| 19 | 17 | |
| 20 | 40 |
About David van de Vijver
David van de Vijver is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 122 papers that have together received 4.2k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (54 papers), HIV Research and Treatment (49 papers) and HIV/AIDS drug development and treatment (37 papers). The work is most often cited by research in Virology (1.8k citations), Infectious Diseases (2.8k citations) and Epidemiology (1.6k citations). David van de Vijver has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Charles A. Boucher, Anne–Mieke Vandamme, Albert D. M. E. Osterhaus, Ricardo Camacho, Marc J. M. Bonten, Marion Koopmans, Guus F. Rimmelzwaan, Brooke E Nichols, Elizabeth A. Lyle and Donald Blom. Their work appears in journals such as Science, Nucleic Acids Research and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.